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ABSTRACT
In human embryonic stem cells (ESCs) the transcription factor Zeb2 regulates neuroectoderm ver-
sus mesendoderm formation, but it is unclear how Zeb2 affects the global transcriptional regulato-
ry network in these cell-fate decisions. We generated Zeb2 knockout (KO) mouse ESCs, subjected
them as embryoid bodies (EBs) to neural and general differentiation and carried out temporal
RNA-sequencing (RNA-seq) and reduced representation bisulﬁte sequencing (RRBS) analysis in neu-
ral differentiation. This shows that Zeb2 acts preferentially as a transcriptional repressor associated
with developmental progression and that Zeb2 KO ESCs can exit from their na€ıve state. However,
most cells in these EBs stall in an early epiblast-like state and are impaired in both neural and mes-
endodermal differentiation. Genes involved in pluripotency, epithelial-to-mesenchymal transition
(EMT), and DNA-(de)methylation, including Tet1, are deregulated in the absence of Zeb2. The
observed elevated Tet1 levels in the mutant cells and the knowledge of previously mapped Tet1-
binding sites correlate with loss-of-methylation in neural-stimulating conditions, however, after
the cells initially acquired the correct DNA-methyl marks. Interestingly, cells from such Zeb2 KO EBs
maintain the ability to re-adapt to 2i1 LIF conditions even after prolonged differentiation, while
knockdown of Tet1 partially rescues their impaired differentiation. Hence, in addition to its role in
EMT, Zeb2 is critical in ESCs for exit from the epiblast state, and links the pluripotency network and
DNA-methylation with irreversible commitment to differentiation. STEM CELLS 2016;35:611–625
SIGNIFICANCE STATEMENT
The transcription factor Zeb2 is critical for exit from the epiblast state in mouse ESCs and
for neural and general differentiation. In addition to its role in EMT it links the pluripotency
network and DNA-methylation with irreversible commitment to differentiation.
INTRODUCTION
Na€ıve mouse embryonic stem cells (mESCs),
primed epiblast stem cells (EpiSCs), and
embryonic germ cells are pluripotent cells that
can be used as cell culture models to study
pluripotent cell states and fate decisions that
occur during embryogenesis [1–6], transitions
that require changes of the transcriptome and
methylome. The ground state of self-renewing
mESCs can be achieved by simultaneous addi-
tion of chemical inhibitors (of MAPK and GSK3
signaling) and LIF (referred to as 2i1 LIF) [7].
When compared to a population of na€ıve
embryonic stem cells (ESCs), ground-state ESCs
display higher and more homogeneous expres-
sion of key pluripotency genes, lower levels of
differentiation markers and reduced DNA-
methylation [8, 9].
DNA-methylation status has profound
effects on embryonic gene expression. It is
controlled by DNA (cytosine-5)-methyltransfer-
ases (Dnmt3a/3b/3l) that are highly active in
ESCs and early embryos and establish new
methylation patterns and by Dnmt1 that cop-
ies the patterns onto daughter cells [10, 11].
Active demethylation is orchestrated by Ten-
eleven translocation methylcytosine dioxyge-
nases (Tet) [12, 13]. Tet1 levels are high in
ESCs and decrease upon differentiation, corre-
lating with exit from pluripotency, and Tet1
steers mesendoderm versus trophectoderm
decisions in preimplantation embryos [14, 15].
Tet1 is also important during somatic reprog-
ramming for genome demethylation as well as
activation/maintenance of Oct4 and Nanog
[16–18].
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Zeb2 (Sip1, Zfhx1b) downregulates E-cadherin (Cdh1) and
thereby steers epithelial-to-mesenchymal transition (EMT)
[19], which is relevant to stem cell fate, but also tumorigene-
sis [20, 21]. Mutations in ZEB2 cause Mowat-Wilson syndrome
(MOWS; OMIM#235730), including defects in the central and
peripheral nervous system (CNS, PNS) [22–24]. Many in vivo
studies conﬁrm the critical roles of Zeb2 in embryogenesis
and neurodevelopment in particular. Zeb2 KO mice die shortly
after E8.5 and have multiple defects, including in somitogene-
sis [25], the neural plate and neural crest cells [26]. Cell-type
speciﬁc Zeb2 KO mice develop defects in, for example, the
CNS [27–29] and PNS [30–32]. Such studies in embryonic
brain revealed cell autonomous, but also non-autonomous
Zeb2 actions. In human (h) ESCs, Zeb2 regulates cell fate:
upon Zeb2 knockdown (KD) they commit toward mesendo-
derm, while Zeb2 overproduction enhances neurogenesis [33].
ZEB2 is controlled by Nanog, Oct4, and Sox2 in hESCs, but key
genes downstream of Zeb2 in ESCs, and during early neural
development, remain to be determined, and Zeb2 KO hESCs
have not been reported. In order to enter lineage commit-
ment, the pluripotency network in ESCs and EpiSCs needs to
be distinguished [34, 35]. The list of factors promoting exit
from na€ıve or ground state is growing, yet more key players
remain to be identiﬁed [36–38]. Exit from pluripotency
beyond the primed epiblast state requires efﬁcient, irrevers-
ible silencing of the transcriptional pluripotency network
(including Oct4 and Nanog silencing, which persist in EpiSCs),
acquisition and maintenance of DNA-methyl marks, and initia-
tion of differentiation.
Using Zeb2 KO ESCs, we identiﬁed Zeb2 as a critical player
for initiating and executing the differentiation programs. Upon
withdrawal of 2i1 LIF from Zeb2 KO ESC populations, some
cells only sometimes commit to differentiation, but instead
the gross population usually stalls as pluripotent, epiblast-like
cells that maintain the ability to re-adapt to 2i1 LIF even
after prolonged exposure to differentiation protocols. The
defective silencing of the pluripotency program prevents these
Zeb2 KO cells from undergoing neural and general (including
mesendodermal) differentiation. RNA-seq revealed that Dnmt
and Tet family mRNA levels are deregulated in Zeb2 KO cells.
Such cells correctly acquire methyl marks early during neural
differentiation (ND), but do not maintain these and revert to
a more na€ıve methylome state. Tet1 levels depend on the
presence of Zeb2 and in Zeb2 KO cells (displaying elevated
Tet1) Tet1 KD rescues their ability to exit from their pluripo-
tent state and re-enter lineage commitment.
MATERIALS AND METHODS
ESC Lines
All experiments on live mice used for deriving embryos for
establishing the ESCs were performed in the Leuven lab
according to institutional (KU Leuven P153/2012), national
(lab license LA1210584, Belgian government) and international
(2010/63/EU) guidelines and regulations. KU Leuven approved
the experiments and conﬁrmed that all experiments were
done conform to the regulatory standards.
Two independent ESC derivations were performed. First,
control lines were derived by interbreeding Zeb2ﬂox/ﬂox CD1
mice [39]. Blastocysts were plated on mitomycin-C inactivated
mouse embryonic ﬁbroblasts (mitC-MEFs) in ESC derivation
medium1 LIF, and allowed to attach, and were re-fed daily.
After 5–6 days, the inner cell mass was separated from the
trophectodermal layer, trypsinized and replated on mitC-MEFs.
They were further grown until subconﬂuency and expanded.
From these ESCs, Zeb2 KO lines were derived by nucleofection
of linearized, blasticidin-selectable (48 hours) pcDNA6-His-
eGFP:Cre vector to low-passage ESCs using Amaxa A-23
(Lonza, Braine-l’Alleud, BE, www.lonza.com). Five control ESC
lines and two KO lines, conﬁrmed as such by genotyping
(details available on request), were established. Second,
Zeb21/- mice were crossed with R26-iPSC mice that contain a
RMCE cassette in the ROSA26 (R26) locus [40]. The second
R26 allele contained the LacZ reporter [41]. New control and
RMCE-compatible Zeb2 KO ESC lines (three clones; mixed
129/Bl6 background) were derived using a protocol [42] in
which pluripotin was replaced with 1 mM PD0325901 and 3
mM CHIR99021. To obtain R26_Zeb2 lines, RMCE technology
[43] was used to insert N-terminally Flag epitope (Flag)
tagged, wild-type Zeb2 cDNA into R26 of Zeb2 KO ESCs.
ESC Cultures and Sorting
ESC maintenance: ESCs were maintained feeder-cell free in
2i1 LIF medium. N2B27 was prepared as described [44]. For
2i1 LIF medium, 1 lM PD0325901 (Axon, 1408, Axon Med-
chem, Groningen, NL, www.axonmedchem.com), 3 lM
CHIR99021 (Axon, 1386) [7], and 1,000 U LIF/ml (Millipore,
ESG1107, Merck Millipore, Zwijndrecht, BE, www.merckmilli-
pore.com) were added. Directed neural differentiation: On d0,
3 3 106 ESCs were plated in a 10-cm bacterial petri dish in
embryoid body (EB) medium (KO DMEM (Invitrogen,
10829018, Thermo Fisher Scientiﬁc, Merelbeke, BE, www.ther-
moﬁsher.com), 15% fetal bovine serum (FBS, Life Technolo-
gies, 10270106, Thermo Scientiﬁc, Aalst, BE, www.ﬁshersci.be/
be), 0.1 mM nonessential amino acids (NEAA), 1 mM sodium
pyruvate, 0.1 mM 2-mercaptoethanol, 50 U/ml of penicilline/
streptomycine, P/S). On d2 the EB medium was refreshed; on
d4 it was changed to N2B271 retinoic acid (Sigma-Aldrich,
R2625, Overijse, BE, www.sigmaaldrich.com; 500 nM) and
refreshed on d6. Between d8 and d15 EBs were cultured in
N2B27, which was refreshed every other day. General EB dif-
ferentiation: On d0, 3 3 106 ESCs were plated in a 10-cm
dish in EB medium (KO DMEM Invitrogen, 10829018), 10%
FBS, 0.1 mM NEAA, 1 mM sodium pyruvate, 0.1 mM 2-
mercaptoethanol, 50 U/ml of P/S and changed every other
day till d15. EBs on d15 were dissociated using Liberase
(Roche, 05401020001, Roche Biochem Reagents, Overijse, BE,
www.sigmaaldrich.com). Living cells were stained with propi-
dium iodide (Sigma-Aldrich, P4864) shortly before sorting.
ESC-to-EpiLC conversion: ESCs were differentiated according to
Hayashi et al. [45]. Brieﬂy 105 ESCs were plated per well of a 12-
well plate coated with ﬁbronectin (16.7 lg/ml, Millipore,
FC010) in N2B27 containing Activin A (20 ng/ml, Peprotech,
120-14E, Peprotech via Bio-Connect, Huissen, NL, www.pepro-
tech.com), bFGF (12 ng/ml, Peprotech, 100-18C), and KSR (1%,
Gibco, 10828010, Gibco, Merelbeke, BE, www.thermoﬁsher.
com). Medium was changed after 24 hours. The EpiLCs were col-
lected after 48 hours.
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shRNA-Mediated Knockdown
Control shRNA was used by combining MISSION Target shRNA
in control vector SHC002 (Sigma-Aldrich). The Tet1 shRNA
(shTet: 50-tcatctacttctcacctagtg-30) was cloned into pLKO1.
Control and Tet1 lentiviruses were produced by standard
methods (see www.addgene.org/tools/protocols/pLKO).
Chromatin Immunoprecipitation
107 ESCs (from the R26_Zeb2 line) were used per experiment.
Cells were cross-linked for 10 minutes with ice-cold 1% formal-
dehyde, sonicated using a Branson Digital Soniﬁer (10 pulses, 30
seconds ON; 60 seconds OFF, amplitude 10). 10 mg of anti-Flag
(Sigma-Aldrich, F3165) and 10 mg of control mouse IgG (Santa
Cruz, sc-2025, Santa Cruz Biotechnology via Bio-Connect,
Huissen, NL, www.scbt.com) were used. Chromatin isolation
and chromatin immunoprecipitation (ChIP) were done as
described [46]. Phenol-chloroform puriﬁed DNA was used as
template for qPCR to amplify the proximal promoters of Nanog
and Cdh1. For primers, see Supporting Information Table SII.
Immunohistochemistry and Indirect
Immunofluorescence
EBs were ﬁxed overnight with 4% paraformaldehyde followed
by progressive alcohol-assisted dehydration and parafﬁn
embedding. 6-lm sections were used for Immunohistochemis-
try (IHC) and Immunoﬂuorescence (IF), which were carried
out on Ventana Ultra Discovery (Roche, Vilvoorde, BE, www.
ventana.com). The following antibodies were used: Zeb2 (cus-
tom antibody; Seuntjens et al., 2009), bIIITubulin (Abcam,
ab78078), Oct4 (Abcam, ab19857, Cambridge, UK, www.
abcam.com), Nanog (Abcam, 80892), Cdh1 (BD Transduction
Labs, 610182, Erembodegem, BE, www.bd.com), Tet1 (Milli-
pore, 09-872), Desmin (Abcam, ab8592-500), Hnf4a (Abcam,
ab41898), Sox17 (R&D Systems, AF1924, Abingdon, UK, www.
rndsystems.com), and Alexa Fluor tagged secondary antibodies
(Jackson Immunoresearch; 1:1,000, via Bio-Connect, Huissen,
NL, www.jacksonimmuno.com). For Figure 1A, ESCs were ﬁxed
for 10 minutes with ice-cold paraformaldehyde and blocked
for 30 minutes at 248C with 0.1% Triton X100-1% BSA in PBS.
Anti-Oct4 (Abcam, ab19857) and anti-Nanog (Abcam, 80892)
(both 1:1,000) were used as antibodies, with DAPI as nuclear
counterstain (Life Technologies, D1306).
For the quantiﬁcations presented in Supporting Informa-
tion Figure S7 (for Oct4, Hnf4a, Sox17, Tet1, and bIIITubulin),
we manually quantiﬁed (using Fiji software) the number of
positive cells as well as total numbers of DAPI1 cells and
show the results as percentage (of 1cells/total) instead of
showing absolute cell numbers, because embryoid bodies
have varying sizes. For the two non-nuclear markers, E-
cadherin and Desmin, we used Fiji software to calculate the
total area of staining and we normalized it to the total area
of DAPI staining. We made the graphs and did the statistical
analysis using Prism7 software.
High-Throughput Real-Time PCR
In a ﬁrst step non or unreliably expressed genes were
removed based on quality information and a minimum
threshold of 50% detection in all samples. Next, low quality
samples were removed based on outlier detection of aggrega-
tion scores of all assay expression probabilities, calculated in
all samples. Subsequently Ct values of the samples were
quantile normalized and possible missing values were imputed
using expression information of biological replicates. An over-
all limit-of-detection (LOD) was determined as the sum of the
75% quantile of normalized Ct values and a constant, that is,
10. To compare between assay levels and display on the
graphs we retrieved log2 expression values by subtracting the
LOD score with normalized Ct values and obtained rough
absolute expression estimations by raising 2 to the power of
the log2 score.
RNA-Seq Analysis
Total RNA was isolated using a Qiagen RNeasy (Qiagen, 74104,
Antwerp, BE, www.qiagen.com). cDNAs were generated with
Truseq RNA kit and sequenced (Illumina TruSeq v3 protocol on
HiSeq2000, with a single read 36 bp and 7 bp index).
Sequenced fragments were mapped to the mouse genome
GRCm38 (Ensembl) using Tophat2 (v2.0.13). A count table for
annotated genes was generated with featureCounts (v1.4.6);
genes were further classiﬁed in different biotypes based on Vega
gene and transcript annotation (vega.sanger.ac.uk/info/about/
gene_and_transcript_types.html). RNA-seq expression data: to
compare counts between samples we converted them to Tran-
script Per Million (TPM) values. To retain only informative genes
we ﬁltered based on biotype, expression and standard variability
using the aforementioned TPM values. First, we removed all
genes belonging to short noncoding categories, in the next step
we selected only these genes that have at least ﬁve transcripts/
million in at least three samples and, ﬁnally, we removed the
20% lowest variable genes. The raw counts were imported in
the R-Package DESeq2 [47] to test for differential expression
between pairwise time-points of KO and Ctrl samples or to per-
form time-series analysis, therefore we created a design matrix
that controls for differences at d0 and allows to assess the effect
of factor time on gene expression between KO and Ctrl samples.
RNA-seq clustering: we used Principal Component Analysis (PCA)
or unsupervised hierarchical clustering based on 1—Spearman
correlation distance scores with average linkage. RNA-seq gene
ontology: to identify biological processes that are negatively
enriched in Zeb2 KO, we sorted genes according to their pi-value
(2log 10[q value] * log FC) based on DESeq2 time-series analy-
sis. The obtained ranked list was input for the GseaPreranked
tool with only –nperm 3,000, -set_max 500 -set_min 10 deviat-
ing from the default parameters. RNA-seq motif sequence analy-
sis: for imple motif analysis between KO and Ctrl at d6 we
deﬁned promoter regions as6 2 Kb from the transcription start
site (TSS) and counted the occurrences for putative binding site
of Zeb2 (double YACCTG sequences with maximum gap of 40
bp) for all (up and down) differentially expressed genes (DEGs)
(p < 0.01 and absolute log 2 FC > 1) and, as background, the
promoter regions of all genes. One-sided Fisher’s exact test was
used to determine signiﬁcant over or under representation of
this motif in promoter regions of DEGs relative to the genome-
wide promoter regions.
Data deposition: the RNA-seq data have been deposited
as data set GSE75618 and are available at www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc5GSE75618.
DNA-Methylome Analysis by RRBS
Total DNA was isolated by digestion with proteinase K and precipi-
tation with isopropanol. RRBS was performed by NXT-Dx (www.
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nxt-dx.com) using the premium RRBS kit (Diagenode). RRBS proc-
essing: the quality of sequencing reads was assessed by FastQC
(v0.11.3_devel) and Trim Galore (v0.3.7) in –rrbs mode. These
reads were then mapped to genome GRCm38 (Ensembl) using
bismark (v0.14.1) with parameters –bowtie2 –maxins 1,000, allow-
ing a maximum insert size of 1,000 bp for paired-end sequences.
To extract methylation information in a CpG context from both
strands we used bismark_methylation_extractor with parameters
Figure 1. Knockout of Zeb2 impairs embryonic stem cells (ESC) neural differentiation (ND) (for general differentiation [GD], see Sup-
porting Information Fig. S1). (A): Scheme of the 15-day ND protocol; RA: retinoic acid. (B): RT-qPCR of Zeb2 in Ctrl ESCs during ND. SD
of two technical replicates is shown. (C): Immunohistochemistry for Zeb2 (brown) in Ctrl embryoid bodies (EBs) (Ctrl) on d6 and d15 of
ND. (D-F): Ctrl and Zeb2 KO (KO) ND-EBs stained for Nestin (red, panel D) on d12, bIIITubulin (green, panel E) on d15 and costained
for MAP2 (green) and GFAP (red) on d15 (panel F). Scale bars: 50 mm. Results shown are from one experiment and are representative
for three experiments. (G) Heatmap for samples collected in pluripotency and during ND and GD with clustering based on Spearman
correlation distances of quantile-normalized RT-qPCR values. Abbreviation: ND, neural differentiation.
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–paired-end –no_overlap –comprehensive. We used the R-package
methylKit [48] and custom R-scripts to further analyze the data. In
brief, we considered only CpGs with a minimum sequencing depth
of 5x and removed the top 0.1% with highest coverage. To visualize
global percentage methylation, histograms were created with 5%-
methylation bins. For all further analyses, we only retained CpGs
that were present in all samples. RRBS genomic regions: genomic
coordinates for genes were retrieved from GRCm38 and only coor-
dinates for protein-coding genes were used.We downloaded mm9
enhancer coordinates provided at http://chromosome.sdsc.edu/
mouse/download.html, converted them to mm10 coordinates
using CrossMap (v0.1.8), and extended them in both directions
with 1 kb. CpG islands (CGI) and transposable elements (TE) were
retrieved via the UCSC table browser for GRCm38/mm10, with the
CGI and RepeatMasker tracks, respectively. The genomic coordi-
nates for Canyons were retrieved from [49]. We used a CpG
observed/expected ratio of 0.29 to distinguish low and high-CpG
density promoters [50]. Regions that do not belong to any of the
aforementioned regions (e.g., intergenic regions) are described as
“other.” RRBS data analysis: to identify differentially methylated
regions (DMRs) and analyze global methylation dynamics/differ-
ences we averaged methylation in 400bp-tiles containing at least
three CpGs. Tiles with more than 20% difference in methylation
and a q value <0.05 were assigned as signiﬁcant DMRs, or simply
DMRs.
Data deposition: the methylome analysis data have been
deposited as a data subset of GSE75618 and are available at
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc5GSE75618.
Analysis of Published Tet1-Binding Peaks in ESCs
Data for Tet1 ChIP-seq for mouse ESCs was downloaded from
GEO (GSM659803, GSM659799). Reads were aligned to
GRCm38 using bowtie with parameters –e 70 –k 1 –m 1 –n 2
–concise. Peaks were indicated with MACS software using
default parameters. To study enrichment of Tet1 at demethyl-
ated regions, peaks were assigned to the closest demethyl-
ated region.
RESULTS
ESC Differentiation is Impaired in Absence of Zeb2
We generated Zeb2 KO [26, 39] along with Zeb2ﬂox/ﬂox control
mESCs (Ctrl). In 2i1 LIF, these ESC lines as population main-
tain high Nanog and Oct4 (Supporting Information Fig. S1A),
proliferate comparably (Supporting Information Fig. S1B) and
have a high and similar clonogenic capacity (670%, not
shown), showing that Zeb2 is dispensable for pluripotency
and self-renewal in ground-state conditions.
Because of the documented role of Zeb2 in neural devel-
opment [22–24, 27–29] we investigated ND of Zeb2 KO ESCs,
subjecting them as EBs to ND using retinoic acid [modiﬁed
from Ref. 51] (Fig. 1A). In Ctrl EBs, the very low Zeb2 mRNA
levels increased between day d0 and d4 after withdrawal of
2i1 LIF as well as during the acquisition of neural fate
(between d4 and d6) and remained high till the end of our
15-day ND protocol (Fig. 1B). The ﬁrst Zeb2-positive (Zeb21)
cells are detected by IHC on d6, being intense from d8 (not
shown) till the end of the experiment (Fig. 1C). Absence of
neural progenitor (Nestin1), neuronal (bIIITubulin1, Map21),
and astroglial (GFAP1) markers (IF; Fig. 1D-1F; for
quantiﬁcations of neural conversion for the ESC lines dis-
cussed here and for other lines, see Supporting Information
Fig. S7, here panel C) showed that ND was abolished in Zeb2
KO EBs. Thus, Zeb2 is crucial for mESCs to acquire neural fate,
in line with observations that Zeb2 KD in hESCs makes these
cells favor mesendoderm over neuroectoderm fate [33].
To validate whether Zeb2 genetic inactivation of in mESCs
would also yield increase in mesendoderm, we subjected
Zeb2 KO ESC to general differentiation (GD; Supporting Infor-
mation Fig. S1C) allowing commitment to all cell fates for
15d, and monitored Zeb2 mRNA/protein in Ctrl cells (Support-
ing Information Fig. S1D, 1E) and stained for mesoderm,
endoderm, and neural markers, respectively (Supporting Infor-
mation Figs. S1F-1H, S7E-7G). This showed that Zeb2 KO mESC
have impaired early differentiation not restricted to ND, but
which affects all three germ layers.
Gene expression changes in Zeb2 KO mESCs after expo-
sure to differentiating cues were also analyzed via 40 marker
mRNAs for neuroectoderm, mesoderm, endoderm and pluri-
potency, respectively, using reverse transcription quantitative
polymerase chain reaction (RT-PCR) on d0, 4, 6, and 15 in Ctrl
and Zeb2 KO cells, in ND and GD. Importantly, Zeb2 “rescue”
ESC lines were included in this RT-qPCR analysis (d0 and d15;
Supporting Information Fig. S2F, 2G) by introducing Zeb2 (N-
tagged with Flag3/Strep-tag) as cDNA in R26 (see Supporting
Information Experimental Procedures) of Zeb2 KO cells (here-
after named R26_Zeb2). This restored the differentiation of
these ESCs (IHC/IF, RT-qPCR, see Supporting Information Figs.
S2A-2E, S7C, 7E-7G). The expression heatmap (Fig. 1G) with
samples clustered based on quantile-normalized expression
values showed clear separations between d15 Ctrl and
R26_Zeb2 cells both in GD and ND, the d6 Ctrl in ND, and the
rest of the samples including d15 Zeb2 KO cells, further sup-
porting our observation that Zeb2 KO ESCs stay largely
uncommitted and display overall reduced differentiation
capacity.
Zeb2 Acts Preferentially as a Transcriptional Repressor
Associated with Developmental Progression
Temporal RNA-seq of Ctrl and Zeb2 KO ESCs would show in
more detail Zeb2-dependent effects on early cell-state/fate
decisions and identiﬁed potential mediators of the impaired
differentiation phenotype downstream of Zeb2. Here we
chose ND wherein we can distinguish three stages that corre-
spond in Ctrl cells to (i) ground-state ESCs (d0, very low Zeb2
mRNA/protein), (ii) multipotent progenitors (d4, low Zeb2,
cultured in presence of serum, induction of markers of three
lineages are observed) (for details, see Supporting Information
Fig. S3A-3C; trophectoderm markers are documented in Sup-
porting Information Fig. S3D), and (iii) early neural progenitors
(d6, high Zeb2). For each stage we performed RNA-seq for
three independent experiments. PCA illustrated that both Ctrl
and Zeb2 KO on d0 are situated close together, but on d4
they already follow different trajectories (Fig. 2A). This coin-
cides with the ﬁrst induction of Zeb2 (between d0 and d4 in
Ctrl; Fig. 1B), indicating that Zeb2 inﬂuences cell-fate decisions
very early-on when cells normally exit from their ground-state
and undergo lineage priming.
To gain insight into what processes might be involved in
the establishment of the early differences between Ctrl and
Zeb2 KO cells, we identiﬁed the top positive and negative
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genes that contribute to principal component 2 (PC2, which
separates the lineage trajectories of Ctrl and Zeb2 KO samples
on the PCA plot) and performed gene ontology (GO) analysis
using Gorilla software [52]. This revealed that the top-100
genes associated with Zeb2 KO cells were enriched for terms
that relate to peptide biosynthesis and metabolism, while the
Figure 2. Analysis of temporal RNA-seq. (A): Principal component analysis based on transcripts per million (TPM). (B): GSEA-P for differentially
expressed genes (DEG) in time-series analysis. The height of the bar plot represents signiﬁcance and the corresponding negative enrichment
score is indicated (blue). (C): Bar plot displays numbers of DEGs using pairwise DESeq2 test (|log 2FC| > 1 and p < 0.01). Colors represent
binned absolute log2FC levels. (D): Promoter analysis for putative bipartite Zeb2-binding motifs (CACCT/CACCTG sequences with maximum gap
of 45 bp; see main text) of DEGs between Zeb2 KO versus Ctrl. Red bar5 selective analysis for upregulated DEG, demonstrates statistical over-
representation (Fisher’s exact test p value5 1.044e-08). Green bar5 selective analysis for downregulated DEG points to underrepresentation.
(E-H): TPM bar plots at the indicated time points for pluripotency-related genes (E), selected epithelial-to-mesenchymal transition genes (F) and
selected methylation-related genes (G) and epiblast (H). Abbreviations: DEG, differentially expressed genes; TPM, transcripts per million.
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top-100 genes associated with Ctrl cells were mainly enriched
for epigenome-related terms, such as histone modiﬁcation
and chromatin organization (for the gene lists, see Supporting
Information Table SIII).
We next applied a time-series analysis (see Materials and
Methods) on our RNA-seq data set to assess the effect of the
factor “time” and identify genes that have a different dynamic
expression proﬁle in KO versus Ctrl cells (Supporting Informa-
tion Table SIV, RNASeq_Time_Series). Gene set enrichment
(GSEA) analysis [53] of genes displaying this different dynamic
behavior showed strong negative enrichment for various dif-
ferentiation/developmental categories within the top-10 hits
(Fig. 2B) and further conﬁrmed that at least the vast majority
of Zeb2 KO cells in EBs indeed remain uncommitted. We also
(re-)conﬁrmed that Zeb2 KO cells do not acquire neural fate
(using Pax6, Zfp521, and Neurog1; Supporting Information
Fig. S3A). The early-neuroectoderm markers Gbx2 and Hoxa1
previously shown to be correctly induced upon differentiation
in Zeb2 KD hESCs [33], were not induced in Zeb2 KO mESCs. This
indicates that genetic inactivation of Zeb2 results in a more
severe neural acquisition phenotype than the KD (Supporting
Information Fig. S3A). We examined the expression of other cell
lineage markers in our RNA-seq data to exclude that Zeb2 KO
cells would preferentially induce non-neural fates (Supporting
Information Fig. S3B-3D). Although a small increase in those
markers was observed in Ctrl EBs, they were either almost
absent (for mesoderm, Supporting Information Fig. S3C) or
markedly lower (trophectoderm and endoderm; Supporting
Information Fig. S3B, 3D) in Zeb2-deﬁcient EBs.
While this RNA-seq data analysis signiﬁcantly expands our
previous characterization of the cells and conﬁrms that Zeb2
inactivation globally affects ESC differentiation, it also provid-
ed the possibility to discover potential Zeb2-dependent candi-
date genes responsible for the impaired differentiation of
Zeb2 KO ESCs. Therefore, we performed pairwise RNA-seq
analysis at all three time-points and identiﬁed DEGs (p value
<0.01 and log 2 Fold Change (FC) >1; Supporting Information
Table SV, RNAseq_Pairwise). Consistent with the divergent
PCA trajectories we observed an increase in both number of
DEGs and their FC over time (Fig. 2C).
Upon neural induction the majority of genes that were
either up or down on d4 (multipotent progenitor stage) main-
tained this status on d6 (early neural progenitor), 69% and
72%, respectively. Numbers of DEGs increased between d4
and d6. To further ﬁlter for direct transcriptional regulation by
Zeb2 we performed binding motif analysis within promoters
(2 kb up and downstream of the transcription start site, TSS)
of DEGs. We searched for two motifs, the E-box sequence 50-
CACCTG-30 and 50-CACCT-30, interspaced by 45 bp max [54].
The genes upregulated during differentiation in Zeb2 KO cells
showed an increase in enrichment for the selected Zeb2-
binding motifs (Fig. 2D, red bars and line), while the opposite
trend was observed for downregulated genes (Fig. 2D, green
bars and line). This suggests that Zeb2 functions preferentially
as a transcriptional repressor during differentiation.
Zeb2 KO ESCs Stall in an Epiblast-like State
Zeb2-deﬁciency leads to impaired differentiation of ESCs and
Zeb2 preferentially acts as repressor. We, therefore, investigat-
ed whether the pluripotency network was properly silenced in
Zeb2 KO ESCs, in particular the genes associated with the
na€ıve state and known as rapidly downregulated upon with-
drawal of 2i1 LIF [38]. Klf4, Tbx3, Zfp42, Prdm14, Essrb,
Nr0b1, and Dppa3 were all properly downregulated in both
Zeb2 KO and Ctrl ESCs (Fig. 2E, upper panel). However, a sig-
niﬁcant set of factors that are part of a larger pluripotency
network or involved in initiation of differentiation were not at
all or only partially downregulated, such as Lefty2, Tcea3,
Dppa5a, Utf1, and Tdgf1 [44, 45] (Fig. 2E, lower panel). This
group also included Pou5f1 and Nanog, key players in the
acquisition of pluripotency and early development [55, 56].
All genes in the latter group contain putative binding sites for
Zeb2 within 2 kb from their TSS, suggesting that Zeb2 is a
candidate direct repressor of (at least some) genes involved
in pluripotency maintenance. In line with the role of Zeb2 in
EMT [19] we observed that in Zeb2 KO cells Cdh1expression
remains high, Epcam is strongly induced and Cdh2, Snai-1/2,
Twist1, and Zeb1 were not induced to the same extent in dif-
ferentiation conditions (Fig. 2F). This conﬁrms that these ESCs
have defective EMT consistent with previously documented
roles of Zeb2, including downregulation of Cdh1, in other cell
types.
Both Dnmt3b (Fig. 2H) and Dmt3l (Fig. 2G) have putative
Zeb2-binding sites and were upregulated in Zeb2 KO during
differentiation. Together with other genes they determine
DNA-methylation at this stage, hence we monitored Dnmt1,
Dnmt3a, Tet1, Tet2, and Tet3 expression [10, 12, 14, 15]. In
addition to high expression of all three Dnmt3 genes, the
Tet1/2 to Tet3 expression switch is only partially achieved; it
normally occurs during transition from pluripotent stem cells
to differentiated cells [15], but in our case Tet3 induction is
limited and Tet1 expression is higher (Fig. 2G).
Although EBs are inherently heterogeneous, all our afore-
mentioned results indicate that at least part of the cells are
stalled in an epiblast-like cell state in which early epiblast
markers are induced whereas a number of pluripotency genes
gets downregulated [45, 56, 57]. We observed a strong
increase of expression of the established postimplantation
epiblast genes Otx2, Pou3f1 (Oct6), Dnmt3b, Zic2, and Fgf5
[53, 58] (Fig. 2H). This data suggests that at least a fraction of
Zeb2 KO cells undergoes lineage priming and acquires
epiblast-like cell (EpiLC) features.
Zeb2 KO ESCs Display Less Efficient
ESC-to-EpiLC Conversion
To test whether Zeb2 KO cells could acquire to epiblast-like
fate, we subjected them (in parallel with the Ctrl line) to a 48
hour-long ESC-to-EpiLC conversion [45] and examined the
transcriptional changes, using high-throughput qPCR (see
Materials and Methods), of a set of markers shown to be
comparably and differentially expressed, respectively, between
ESCs and EpiLCs [based on Ref. 55]. To evaluate whether EpiLC
acquisition depends on the presence of Fgf21ActivinA, we
included also samples of 48 hour-long differentiation in pure
N2B27. There were no obvious morphological differences
between Ctrl and Zeb2 KO cells in 2i1 LIF or after 48 hours
ESC-to-EpiLC conversion and both lines acquired more ﬂat
morphology (Fig. 3A).
First, we analyzed expression of Nanog, Oct4 and Sox2,
which according to Buecker and coworkers are comparable
between ESCs and EpiLCs [57]. Nanog was downregulated in
both Ctrl and Zeb2 KO lines after 48 hours, but in the Zeb2
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KO cells it was still expressed at higher levels (for Nanog
downregulation, see [45]). Oct4 was retained in Ctrl cells and
slightly increased in the Zeb2 KO cells after 48 hours, while
Sox2 was downregulated and retained, respectively (Fig. 3B).
Next, we looked at Nr0b1, Prdm14, Zfp42, Esrrb, Klf2, and
Klf4, which should be expressed at higher level in ESCs as
compared to EpiLCs. All these markers were found downregu-
lated in both lines, but in the Zeb2 KO line Nr0b1, Zfp42, and
Klf2 continued to display higher mRNA levels as compared to
Ctrl cells, whereas Prdm14, Esrrb, and Klf4 mRNA reached
after 48 hours similar levels in both lines (Fig. 3C). Last, we
analyzed Dnmt3a, Dnmt3b, Fgf15, Fgf5, Otx2, and Pou3f1, a
set of markers expected to be expressed at lower levels in
ESCs as compared to EpiLCs. With the exception of Dnmt3a in
the Zeb2 KO line, all markers were induced in both Ctrl and
KO cell lines. In particular, Dnmt3b and Otx2 are induced in
Ctrl and Zeb2 KO lines to the same extent, while Fgf5 and
Pou3f1 show higher mRNA levels in Ctrl versus Zeb2 KO cells.
Fgf15 in EpiLC conversion is expressed at higher levels in the
Zeb2 KO line as compared to Ctrl and after 48 hours in
N2B27 its expression is comparable in both lines (Fig. 3D).
Taken together, the results obtained in ESC-to-EpiLC conver-
sion and 48 hours of N2B27 are comparable, meaning that
the transcriptional changes of genes analyzed are not inﬂu-
enced by the presence of Fgf21ActivinA in the medium.
We conclude that, at population level, Zeb2 KO cells pre-
sent with a less efﬁcient conversion to EpiLC phenotype,
likely resulting from a combination of both na€ıve and primed
states. Since epiblast fate requires more efﬁcient pluripo-
tency gene silencing than observed in the Zeb2 KO cells and
a signiﬁcant induction of markers such as Fgf5 and Pou3f1,
we suggest that—in our EBs—a fraction of Zeb2 KO cells
remains in na€ıve ESC state, while the remaining cells may
still undergo EpiLC conversion. Single-cell mRNA analysis is
needed in future experiments to provide insight into the
proportions of cells that stay in the na€ıve versus primed
state as well as revealing the presence of (few) cells pro-
gressing toward differentiation.
Figure 3. Zeb2 KO embryonic stem cells (ESCs) display less efﬁcient ESC-to-EpiLC conversion. (A): Phase-contrast images of Ctrl and
Zeb2 KO cells in 2i1 LIF and after 48 hours of EpiLC conversion. Scale bar: 50 lM. (B-D): RT-qPCR analysis of Ctrl and Zeb2 KO samples
on d0, after 48 hours in EpiLC medium and after 48 hours N2B27 in medium. (B): Transcripts comparable between ESC and EpiLC
(Nanog, Pou5f1, Sox2). (C): Transcripts higher in ESC versus EpiLC (Nr0b1, Prdm14, Zfp42, Esrrb, Klf2, Klf4). (D): Transcripts lower in ESCs
versus EpiLCs (Dnmt3a, Dnmt3b, Fgf15, Fgf5, Otx2, Pou3f1). These three categories (shown in panels B, C, D) are based on [66]. Results
shown are from one experiment; error bars are from three biological samples. Abbreviation: ESCs, embryonic stem cells.
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Pluripotent Potential Is Retained in Zeb2-Deficient
Embryoid Bodies
Pou5f1 (Oct4) and Nanog, two crucial pluripotency-supporting
factors maintained in epiblast cells, remained high (as seen by
western blotting and RT-qPCR, Supporting Information Fig.
S5A, 5B) and were present in a large fraction of cells in Zeb2
KO ND-EBs till d15 (Fig. 4A, 4B). Again, this observation could
be extended to GD-EBs (Supporting Information Fig. S5C, 5D;
d15). In addition, high numbers of Cdh11 cells were observed
in Zeb2 KO EBs (Fig. 4B) and this was also seen at protein
and mRNA levels on d15 (Supporting Information Fig. S5A,
5B). R26_Zeb2 rescue partially restored downregulation of
Oct4 (and Cdh1) mRNA/protein (Supporting Information Fig.
S2C). To conﬁrm that this is the direct result of Zeb2 binding
a ChIP-qPCR was carried out over the Zeb2-binding motif (Fig.
4C, 4D). This showed enrichment of Flag-tagged Zeb2 (using
R26_Zeb2 ESCs) Cdh1 promoter [19, 26] and its new candi-
date target Nanog.
To document the persistence of the pluripotent state upon
differentiation in Zeb2 KO cells, we dissociated Ctrl and Zeb2 KO
EBs on d15 (in ND or GD), sorted the living cells and plated
these at 500 cells/well as single cells in 2i1 LIF. Alkaline
phosphatase (AP)1 ESC colonies derived from EBs subjected to
differentiation (Fig. 4E, 4F) were quantiﬁed on d9 (Fig. 4G). In a
typical experiment, Ctrl cells subjected to ND did not give rise to
AP1 cells, whereas Zeb2 KO cells in 2i1 LIF yielded on average
8 colonies/well. In GD, Ctrl cells gave rise to less than 1 (calculat-
ed 0.2) AP1 colony/well, whereas for Zeb2 KO cells this was 4
colonies/well on average. Based on AP read-out, this shows
these latter cells have the remarkable ability to re-adapt to
2i1 LIF, like ESCs and EpiSCs, and that they form AP1 colonies
even up to d15 of differentiation treatment. Without assess-
ment at single-cell level, we cannot discriminate whether these
AP1 colonies arose exclusively from epiblast-like or more na€ıve
Zeb2 KO cells since both cell types can adapt to 2i1 LIF. Terato-
ma formation, using EBs subjected to ND for 12 days showed
that Ctrl EBs failed to form teratomas, while Zeb2 KO EBs gave
rise to teratomas in 4 weeks (Supporting Information Fig. S5E).
These data show, therefore, that Zeb2 genetic inactivation leads to
maintenance of pluripotency even after prolonged differentiation.
The Zeb2 KO Embryoid Bodies, Subjected to ND, Fail
to Maintain the Initially Acquired DNA-Methylation
Zeb2 KO EBs show impaired cell differentiation and deregulated
expression of the core methylation machinery genes. This
prompted us to examine the acquisition and maintenance of
Figure 4. Pluripotency genes are not efﬁciently downregulated during differentiation in Zeb2 knockout (KO) embryonic stem cells (ESCs).
(A): Control (Ctrl) and Zeb2 KO (KO) embryoid bodies (EBs) stained for Nanog (brown) on d4, d6, and d15 of neural differentiation (ND). (B):
Ctrl and KO EBs costained for Oct4 (green) and Cdh1 (red) on d4, 6, and 15 of ND. Panels A, B show results from one experiment that is repre-
sentative for three experiments. Scale bar: 50 mm. (C, D): Zeb2 chromatin immunoprecipitation (using anti-Flag antibody) on Cdh1 (panel C)
and Nanog promoter (panel D). Results shown are from one experiment and representative for three experiments. SD of two technical
repeats is shown. (E, F): Ctrl and KO ESCs subjected to ND (panel E) and general differentiation (panel F) for 15 days, dissociated and plated
at 500 cells/well in 2i. The resulting ESC colonies (indicated by arrows) were visualized by staining for AP, and panel (G) represents the
average number of AP1 colonies obtained after plating the cells. Abbreviations: ND, neural differentiation; GD, general differentiation.
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CpG-methylation (meCpG) that accompanies the decision of irre-
versible ESC differentiation. Retaining the same time/sample
setups as for RNA-seq and again using ND, single-base proﬁles
were generated of methylation by RRBS in both Ctrl and Zeb2
KO on d0, d4, and d6. The genome of ground-state (d0) ESCs
was globally hypomethylated [59]. On d4 both cell populations
gained methylation in agreement with our observation that
they are in an epiblast-like (for KO) or multipotent (Ctrl) state.
However a signiﬁcant drop of meCpG was observed in the d6
Zeb2 KO cell population, suggesting that part of the CpG methyl-
ation is lost (Fig. 5A). The progressive accumulation of meCpG in
our EBs has a striking resemblance with that observed in vivo
[60], that is, our d0 population proﬁle is similar to blastocyst-
stage embryos (between E3.5 and E4.5), while d4 and d6
Ctrl populations have a similar distribution proﬁle as epiblast
embryos (E6.5). In contrast, KO d6 resembles early-epiblast
embryos (E5.5) with a reduction in meCpG at both gene bodies
and 10kb-ﬂanking regions (Fig. 5B) [60].
We further investigated changes in the (de)methylation pro-
cess by considering CpGs covered in all samples and averaging
methylation in 400bp-tiles, with a total of 1,84,564 tiles. This
identiﬁed differentially methylated regions (DMRs) (absolute
methylation change >20% and q value <0.05) in both a time
and pairwise-dependent manner (Supporting Information Table
SVI, RRBS_Pairwise). Both Ctrl and KO cells signiﬁcantly gained
methylation in respectively 33.8% and 33.5% of all tiles between
d0 and d4 (Fig. 5C, left panels; Supporting Information Fig. S6A).
During this period, no single signiﬁcant loss-of-methylation was
observed (Supporting Information Fig. S6B). Next, between d4
and d6 Ctrl cells maintained a very stable level of methylation
with only little gain or loss-of-methylation, that is, 0.1% of all
tiles (Fig. 5C, right top panel; Supporting Information Fig. S6A,
6B). In agreement with the observed overall lower methylation
at d6 (Fig. 5A, 5B), KO cells had 10 times more tiles (1806 or 1%
of all tiles) with signiﬁcant loss-of-methylation and only 90 tiles
(0.05% of all tiles) with gain-of-methylation (Fig. 5C, right
Figure 5. Analysis of temporal RRBS during neural differentiation. (A): Distribution histogram for individual meCpGs on d0, d4, and d6
in Ctrl and Zeb2 KO populations. (B): meCpG distribution at gene bodies and 10kb-ﬂanking regions of protein-coding genes. (C): Density
plots for pairwise comparisons of meCpG (in 400bp-tiles) between d0 and d4 in Ctrl (top) and d4 and d6 in KO (bottom) cells. (D): Densi-
ty plot for pairwise comparison of meCpG (in 400bp-tiles) on d6 between Ctrl and KO. In C, D the density points increase from purple to
dark red. (E): Enrichment plot of Tet1-binding peaks centered around demethylated regions on d6 in a pairwise comparison between
Zeb2 KO versus Ctrl. (F): Violin plots showing gain and loss-of-methylation over time in identiﬁed genomic regions, that is, enhancers,
CpG islands, canyons, transposable elements, high-CpG content promoters (HCP), low-CpG content promoter, exons, introns, other non-
deﬁned genomic regions, and globally at the whole-genome (genome) in Ctrl and Zeb2 KO cells. Abbreviations: CGI, CpG islands; TE,
transposable elements; HCP, high-CpG content promoters; LCP, low-CpG content promoter.
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bottom panel; Supporting Information Fig. S6A, 6B; see also
Supporting Information Table SVII, RRBS_Temporal). Further-
more, analysis of these aforementioned DMR in both Ctrl and
KO cells revealed that these regions initially acquired methyla-
tion in both Ctrl and KO cells at d4, but this methylation was
only maintained in Ctrl cells (Supporting Information Fig. S6C).
To investigate whether demethylation was selective for spe-
ciﬁc genomic regions, we proﬁled the methylation dynamics of
enhancers, CGI, canyons, TE, high-CpG content (HCP) and low-
CpG content promoters (LCP), exons and introns. As reported
before [49], resistance to gain-of-methylation occurs for canyons
and high-CpG regions (CGI and HCP), while all other regions
(enhancers, TE, LCP, exons, and introns) were susceptible to
gain-of-methylation. In contrast, the Zeb2 KO population is
unable to maintain this methylation initially acquired in all
aforementioned genomic regions (Fig. 5F).
Failure to Maintain Acquired DNA-Methylation During
ND Is Associated with Tet1-Binding; Tet1 Knockdown
in Zeb2 KO ESCs Facilitates Silencing of Nanog, Oct4,
and Cdh1 and Partially Rescues the Lineage
Differentiation Phenotypes
Regions that lose methylation in d6 Zeb2 KO populations
initially acquired methylation comparable to Ctrl (Supporting
Information Fig. S6C). We also compared d6 of both Ctrl and
Zeb2 KO populations and as expected observed a similar num-
ber of tiles with loss-of-methylation (1938, or 1% of all tiles)
(Fig. 5D) and we observed also an increased level of Tet1 (Fig.
2). We, therefore, asked whether the regions that lose methyl-
ation correlate with Tet1-binding. Figure 5E shows that
regions that lose methylation in Zeb2 KO cells are enriched
for Tet1-binding in normal ESCs: we could do this by combin-
ing analysis of published ChIP-seq data for Tet1 in mESCs [61]
with our region-speciﬁc loss of methylation data on d6 (com-
pared between Ctrl and Zeb2 KO). This strongly suggests that
the observed demethylation in the Zeb2 KO cells is an active
process mediated by elevated Tet1 levels in agreement with
DNA-demethylation being initiated at Tet1-binding sites [62].
Tet1 remains high in the Zeb2 KO EBs even on d15 of differ-
entiation in contrast to its normal downregulation during ND
and GD (Fig. 6A, 6B). To test whether high Tet1 levels lead to
inefﬁcient silencing of Nanog, Oct4, and Cdh1 and hence a block
in differentiation of these cells, we transduced control and Zeb2
KO ESC lines with a lentivirus expressing shRNA directed against
Tet1 (called Ctrl_Tet1shRNA, Zeb2KO_Tet1shRNA, respectively).
Tet1 was almost undetectable in Ctrl and Zeb2 KO lines targeted
with Tet1 shRNA (Fig. 6C, 6D; for quantiﬁcations of Tet1 staining,
see Supporting Information Fig. S7A). In 2i1 LIF, the Tet1 KD
lines maintained their undifferentiated characteristics (not
shown). We subjected these Tet1shRNA lines to ND and GD,
respectively, along with the same lines receiving control non-
targeting shRNA (Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA). These
control shRNA lines behaved as expected in differentiation (Fig.
6E-6J), and Zeb2 was indeed absent from Zeb2KO_CtrlshRNA
and Zeb2KO_Tet1shRNA EBs at the end of GD (Fig. 6H) and ND
(data not shown). After 15 days, Zeb2KO_Tet1shRNA cells sub-
jected to either ND or GD efﬁciently decreased Nanog, Oct4,
and Cdh1 mRNA to low levels at the end of GD (Fig. 6E, 6F; ND
data not shown; for quantiﬁcations of Oct4 and Cdh1, see Sup-
porting Information Fig. S7B, 7D). In Zeb2KO_Tet1shRNA lines
subjected to GD, partial rescue of differentiation to mesoderm
(Fig. 6I; for quantiﬁcations of Desmin, see Supporting Informa-
tion Fig. S7G) and endoderm (Fig. 6G; for quantiﬁcations of
Hnf4a and Sox17, see Supporting Information Fig. S7E, 7F) was
observed, but not to neuroectoderm, (data not shown). Partial
rescue of ND was observed only when Zeb2KO_Tet1shRNA cells
were subjected to ND (Fig. 6J; for quantiﬁcation of bIIITubulin,
see Supporting Information Fig. S7C). Thus, Tet1 remains high in
Zeb2 KO cells during differentiation, and forced downregulation
of Tet1 in these cells in such conditions enables decreasing
Nanog, Oct4, and Cdh1 transcription and partially rescues
differentiation. We conclude that Zeb2-deﬁciency during
differentiation leads to higher Tet1, which is associated with
improper reduction of Nanog and Oct4, resulting in impaired
differentiation.
DISCUSSION
Using Zeb2 genetic inactivation in ESCs for the ﬁrst time as
well as rescue in such Zeb2 KO cells via reintroduction of R26-
driven Zeb2-cDNA, Zeb2 is shown critical for these cells to
undergo three-lineage differentiation. We propose that Zeb2
drives lineage commitment and speciﬁcation by acting on
multiple sets of Zeb2-dependent genes. First, Zeb2 is an
important EMT-inducer [19]. Zeb2 KO ESCs retain epithelial
characteristics when subjected to differentiation. Their pheno-
type appears even more severe than the recently described
KO in ESCs of another known EMT-regulator, Snai1, which still
differentiate [63]. Second, the downregulation of important
pluripotency network regulators depends on Zeb2. In contrast
to Ctrl, Zeb2 KO ESCs retain high Tet1, Oct4, and Nanog dur-
ing differentiation. In ESCs, Tet1 is involved in a positive regu-
latory loop with Nanog and Oct4. Tet1 co-operates with
Nanog, while the KD of Nanog weakens Tet1-binding to its
targets (including Oct4, Esrrb). Tet1 was also shown to act
downstream of Oct4, and downregulation of Oct4 leads to
decreased Tet1 [14, 15, 17, 18]. Tet1 acts downstream of his-
tone deacetylase Sirt6 to control ESC fate in differentiating
conditions [50]. Also, like in our system, the Tet1 KD allowed
silencing of Oct4 and Nanog and rescued the Sirt6 KO differ-
entiation defect. Thus, Tet1 has a global inhibitory role in reg-
ulating key pluripotency genes during ESC differentiation, and
this work identiﬁes Zeb2 as an (indirect) upstream factor
important for achieving correct Tet1 levels.
We describe a link between Zeb2 and regulation of DNA-
methylation status. Acquisition of DNA-methyl marks during
embryogenesis is thought to be unidirectional [60], but stud-
ies in ground-state na€ıve ESCs and EpiSC, respectively, show
that the methylomes are interconvertible in vitro when differ-
ent conditions are applied [59, 64]. Our RRBS showed that
correct DNA-methylation patterns are initially acquired by
Zeb2 KO cells, but that this pattern cannot be sustained: Zeb2
KO cells revert the methylome to a more na€ıve state, which
agrees with the maintenance of their undifferentiated pheno-
type associated with persistence of Nanog and Oct4. Remark-
ably, this reversion in Zeb2 KO cells is facilitated in absence of
additional cues or signals, like LIF and/or 2i. We hypothesize
that Tet1 levels are maintained by the key pluripotency genes
in Zeb2 KO cells. Steady-state high-Tet1 would then actively
demethylate the genome and contribute to preserving high-
Nanog and high-Oct4 in the mutant cells. Enrichment of Tet1-
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binding at regions that lost methylation in Zeb2 KO cells fur-
ther supports this hypothesis. Tet1 KD in these Zeb2 KO cells
facilitated downregulation of Nanog and Oct4 as well as
Cdh1, but their differentiation phenotype was only partially
rescued.
The aforementioned discussed results raise the question
on how it is possible that Zeb2 KO ESCs, in which Tet1 mRNA
is not downregulated, can still undergo DNA-methylation.
First, the main function of Tet1 may be to actively catalyze
demethylation rather than prevent methylation per se [12,
13]. We hypothesize that between days 0 and 4 the gain-of-
methylation in both Ctrl and Zeb2 KO cells is driven by the
very early events linked to the withdrawal of 2i1 LIF and
entering the primed state of pluripotency. We have, however,
not documented that what seems like an equal total gain in
Ctrl and KO cells, also occurs with the same dynamics
Figure 6. Tet1 knockdown in Zeb2 knockout embryonic stem cells facilitates their deﬁnitive pluripotency exit and partially restores their
neural (neural differentiation [ND]) and general differentiation (GD) defect. (A): RT-qPCR of Tet1 mRNA in Ctrl (blue) and Zeb2 KO (red) lines
on d0, d4, d6, and d15 of ND. SD of two technical replicates is shown. (B): Ctrl and Zeb2 KO embryoid bodies (EBs) stained for Tet1 (brown)
on d4, d6, and d15 of GD. (C): RT-qPCR of Tet1 mRNA on d0 (violet) and d15 (green) in Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA, Ctrl_Tet1shRNA
and Zeb2KO_Tet1shRNA lines. SD of two technical replicates is shown. (D): Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA EBs costained for Tet1
(brown) on d15 of GD. Scale bar B, D: 50 mm. (E-J): Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA, Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA EBs stained
for the indicated markers. (E): Nanog (brown) on 15 of GD. F. Oct4 (green) and Cdh1 (red) on d15 of GD. (G): Hnf4a (brown) on d15 of GD.
(H): Zeb2 (brown) on d15 of GD. (I): Desmin (brown) on d15 of GD. (J): bIIITubulin (red) on d15 of ND. Scale bar: 75 mm. (E-I): Scale bar: 50
mm. In all panels, results shown are from one experiment and representative for three experiments.
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(because we analyzed in detail only days 0 and 4 of differenti-
ation) and altogether reﬂects precisely that these cells under-
go the same changes. In other words, Ctrl cells could be
entering three-lineage differentiation program(s) (which we
were able to conﬁrm by analyzing their transcriptional proﬁle)
whereas Zeb2 KO cells could be stalled in the epiblast-like
state and both changes would manifest by the same gross
methylation pattern. It has been previously published that
there is a large gain of methyl marks in ESCs when they tran-
sit from ground (2i1 LIF) to serum1 LIF conditions, both of
which maintain functional pluripotency [62]. Hence, the
observed acquisition of methyl marks can be partially a reﬂec-
tion of entering the metastable state by the Zeb2 KO cells.
It has previously been shown that Dnmt1 KO ESCs show
decreased total DNA-methylation levels, whereas DNA of Dnmt 1/2
mutant ESCs is still highly methylated [65]. It could be that the
observed loss of DNA-methylation in our Zeb2 KO ESCs on d6 is par-
tially caused by decreased Dnmt1 levels that cannot sustain the
acquired methylation pattern in the presence of high Tet1, which
continuously catalyzes DNA-demethylation. Interestingly, the
expression of Dnmt3a/3b/3l was higher in Zeb2 KO as compared to
Ctrl ESCs. We hypothesize that the observed increase in de novo
methyltransferase gene expression could be a counter-acting mech-
anism to sustain the balance between DNA-methylation and
demethylation. The end result, loss of DNA-methylation, could
hence be due to high constant levels of Tet1 that on itself is sus-
tained by the pluripotency genes.
Using GO analysis (done on PC2), we also noted that aber-
rant chromatin changes and histone modiﬁcations could con-
tribute to the differentiation phenotype in Zeb2 KO ESCs.
ESCs have a unique, open chromatin that changes rapidly
upon cell differentiation, thereby inﬂuencing transcriptional
regulation and cell identity [4, 62]. Given the differences in
the transcriptional proﬁle of Ctrl versus Zeb2 KO ESCs, we
hypothesize that, in addition to the DNA-methylation related
phenotype followed-up here, Zeb2 KO ESCs might also have a
different chromatin (more ESC-like) structure, which contrib-
utes to their undifferentiated phenotype.
It is also likely that Zeb2 controls other important cell fate
regulators at multiple stages of differentiation in addition to
the pluripotency genes and Tet1 investigated here. For exam-
ple, similar to described in vivo functions of Zeb2 in myelino-
genesis in embryonic CNS [32], Zeb2 may also counteract
genes that are inhibitory for neural conversion during ESC dif-
ferentiation; it may also act as an activator of other target
genes depending on its cofactors [66, 67] which altogether
would then promote neurogenesis. Subsequent work will have
to encompass the mapping of the genome-wide binding sites
of Zeb2 in mESCs. As the current anti-Zeb2 antibodies fail
in such studies (not shown), these studies will require an
endogenous tagging approach within Zeb2 to identify Zeb2
DNA-binding sites and also stage-relevant protein partners of
Zeb2.
CONCLUSION
The transcription factor Zeb2 is critical for exit from the epi-
blast state in mouse ESCs and links the pluripotency network
and DNA-methylation with irreversible commitment to differ-
entiation. Zeb2 KO ESCs display impaired differentiation by
stalling in an epiblast-like state. Using RNA-seq, we conclude
that in differentiating conditions EMT, pluripotency, lineage
commitment and DNA-(de)methylation genes are deregulated
in Zeb2 KO embryoid bodies. Using RRBS, we demonstrate
that these cells cannot maintain their initially acquired DNA-
methylation marks in neural-stimulating condition and do not
effectively downregulate Oct4, Nanog, and Tet1 in differentia-
tion conditions. Tet1 KD partially rescues the impaired differ-
entiation of the KO cells.
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